Loring Wolcott & Coolidge Fiduciary Advisors’s Labcorp LH Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$944K	Hold	3,370	–	–	0.01%	183
2026 Q1	$879K	Hold	3,370	–	–	0.01%	179
2025 Q4	$914K	Hold	3,370	–	–	0.01%	178
2025 Q3	$957K	Buy	+3,370	New	+$903K	0.01%	175
2025 Q1	–	Sell	-250	Closed	-$62.4K	–	574
2024 Q4	$62.4K	Hold	250	–	–	﹤0.01%	376
2024 Q3	$57.5K	Hold	250	–	–	﹤0.01%	379
2024 Q2	$54.1K	Hold	250	–	–	﹤0.01%	385
2024 Q1	$50.8K	Hold	250	–	–	﹤0.01%	395
2023 Q4	$55.6K	Hold	250	–	–	﹤0.01%	393
2023 Q3	$51.3K	Sell	250 -41	-14%	-$8.65K	﹤0.01%	415
2023 Q2	$60.3K	Sell	291 -173	-37%	-$33.6K	﹤0.01%	409
2023 Q1	$91.5K	Hold	464	–	–	﹤0.01%	350
2022 Q4	$94K	Hold	464	–	–	﹤0.01%	353
2022 Q3	$82K	Hold	464	–	–	﹤0.01%	367
2022 Q2	$94K	Hold	464	–	–	﹤0.01%	364
2022 Q1	$105K	Buy	464 +173	+59%	+$40.7K	﹤0.01%	369
2021 Q4	$79K	Hold	291	–	–	﹤0.01%	421
2021 Q3	$70K	Hold	291	–	–	﹤0.01%	428
2021 Q2	$69K	Buy	+291	New	+$66.3K	﹤0.01%	443
2021 Q1	–	Sell	-291	Closed	-$51K	–	528
2020 Q4	$51K	Buy	+291	New	+$50.3K	﹤0.01%	425
2019 Q2	–	Sell	-17	Closed	-$2K	–	741
2019 Q1	$2K	Hold	17	–	–	﹤0.01%	644
2018 Q4	$2K	Sell	17 -117	-87%	-$15.7K	﹤0.01%	633
2018 Q3	$20K	Hold	134	–	–	﹤0.01%	493
2018 Q2	$21K	Hold	134	–	–	﹤0.01%	499
2018 Q1	$19K	Hold	134	–	–	﹤0.01%	544
2017 Q4	$18K	Sell	134 -174	-56%	-$23K	﹤0.01%	528
2017 Q3	$40K	Buy	308 +17	+6%	+$2.27K	﹤0.01%	447
2017 Q2	$40K	Hold	291	–	–	﹤0.01%	433
2017 Q1	$36K	Hold	291	–	–	﹤0.01%	446
2016 Q4	$32K	Hold	291	–	–	﹤0.01%	434
2016 Q3	$34K	Hold	291	–	–	﹤0.01%	436
2016 Q2	$33K	Hold	291	–	–	﹤0.01%	435
2016 Q1	$29K	Hold	291	–	–	﹤0.01%	452
2015 Q4	$31K	Hold	291	–	–	﹤0.01%	479
2015 Q3	$30K	Hold	291	–	–	﹤0.01%	466
2015 Q2	$30K	Hold	291	–	–	﹤0.01%	466
2015 Q1	$32K	Hold	291	–	–	﹤0.01%	479
2014 Q4	$27K	Hold	291	–	–	﹤0.01%	484
2014 Q3	$25K	Hold	291	–	–	﹤0.01%	470
2014 Q2	$26K	Sell	291 -274	-48%	-$23.7K	﹤0.01%	490
2014 Q1	$48K	Sell	565 -11,602	-95%	-$925K	﹤0.01%	416
2013 Q4	$955K	Sell	12,167 -2,962	-20%	-$253K	0.03%	150
2013 Q3	$1.29M	Sell	15,129 -3,133	-17%	-$264K	0.04%	130
2013 Q2	$1.57M	Buy	+18,262	New	+$1.52M	0.05%	128

Other funds holding LH

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CapitalatWork SA Auderghem $3.99B AUM

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

JIC

Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's LH Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its Labcorp (LH) position steady in Q2 2026 at 3,370 shares worth $944K. The position accounts for 0.01% of the portfolio, ranked #183.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in LH in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.57M in Q2 2013. 515 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Loring Wolcott & Coolidge Fiduciary Advisors held 3,370 shares of Labcorp worth $944K as of Q2 2026.
Loring Wolcott & Coolidge Fiduciary Advisors left its Labcorp share count unchanged in Q2 2026.
Labcorp made up 0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #183 holding.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Labcorp in Q2 2013 and has held it in 44 quarters since.
Loring Wolcott & Coolidge Fiduciary Advisors's Labcorp position peaked at $1.57M in Q2 2013.
515 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.